Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Abstract 1608: Pharmacologic screening identifies synthetic lethality interactions with Chk1 inhibitors in basal-like breast and ovarian cancer

Eva M. Galan-Moya, Ana Alcaraz-Sanabria, Cristina Nieto-Jimenez, Veronica Corrales-Sanchez, Miriam Nuncia-Cantarero, Juan C. Montero, Atanasio Pandiella, Alberto Ocaña

Cancer Res (2018) 78 (13_Supplement): 1608.

https://doi.org/10.1158/1538-7445.AM2018-1608

Published: 01 July 2018

View articletitled, Abstract 1608: Pharmacologic screening identifies synthetic lethality interactions with Chk1 inhibitors in basal-like breast and ovarian cancer

Journal Articles

The hematopoietic-specific class VI β-tubulin is naturally resistant to the depolymerizing effects of 2-Methoxyestradiol and protects patients from myelosuppressive side effects

Daniel Escuin-Borras, Patricia Burke, Theresa LaVallee, Todd Hembrough, Ana Alcaraz, James Snyder, Paraskevi Giannakakou

Cancer Res (2008) 68 (9_Supplement): 1400.

Published: 01 May 2008

View articletitled, The hematopoietic-specific class VI β-tubulin is naturally resistant to the depolymerizing effects of 2-Methoxyestradiol and protects patients from myelosuppressive side effects

Journal Articles

Tubulin mutations followed by gene silencing of the wild-type class I β-tubulin allele confer resistance to 2-Methoxyestradiol

Daniel Escuin, Yuefang Wang, James Snyder, Ana Alcaraz, Theresa LaVallee, Paraskevi Giannakakou

Cancer Res (2007) 67 (9_Supplement): 2312.

Published: 01 May 2007

View articletitled, Tubulin mutations followed by gene silencing of the wild-type class I β-tubulin allele confer resistance to 2-Methoxyestradiol

Journal Articles

Classification of Proliferative Pulmonary Lesions of the Mouse: Recommendations of the Mouse Models of Human Cancers Consortium

Cancer Res (2004) 64 (7): 2307–2316.

https://doi.org/10.1158/0008-5472.CAN-03-3376

Published: 01 April 2004

View articletitled, Classification of Proliferative Pulmonary Lesions of the Mouse: Recommendations of the Mouse Models of Human Cancers Consortium

Includes: Supplementary data

Update search

NARROW

Format

Journal

Article Type

Issue Section

Date

Availability

Abstract 1608: Pharmacologic screening identifies synthetic lethality interactions with Chk1 inhibitors in basal-like breast and ovarian cancer

The hematopoietic-specific class VI β-tubulin is naturally resistant to the depolymerizing effects of 2-Methoxyestradiol and protects patients from myelosuppressive side effects

Tubulin mutations followed by gene silencing of the wild-type class I β-tubulin allele confer resistance to 2-Methoxyestradiol

Classification of Proliferative Pulmonary Lesions of the Mouse: Recommendations of the Mouse Models of Human Cancers Consortium

Email alerts

AACR Journals

Update search

Abstract 1608: Pharmacologic screening identifies synthetic lethality interactions with Chk1 inhibitors in basal-like breast and ovarian cancer

The hematopoietic-specific class VI β-tubulin is naturally resistant to the depolymerizing effects of 2-Methoxyestradiol and protects patients from myelosuppressive side effects

Tubulin mutations followed by gene silencing of the wild-type class I β-tubulin allele confer resistance to 2-Methoxyestradiol

Classification of Proliferative Pulmonary Lesions of the Mouse: Recommendations of the Mouse Models of Human Cancers Consortium

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only